Literature DB >> 19018949

Correlation between cognitive deficits and glucose hypometabolism in mild cognitive impairment.

Hiroko Nishi1, Nobukatsu Sawamoto, Chihiro Namiki, Hidefumi Yoshida, Ha Duy Thuy Dinh, Koichi Ishizu, Kazuo Hashikawa, Hidenao Fukuyama.   

Abstract

BACKGROUND: In patients with mild cognitive impairment (MCI), poor performances on delayed recall and executive function are risk factors of progression to dementia. The aim of the present study was to clarify neural correlates of these neuropsychological deficits.
METHODS: Thirty patients with amnestic MCI and 15 control subjects underwent neuropsychological tests including three-word delayed recall, visual delayed recall of Rey complex figure (RCF), and two-relational reasoning of Raven's colored progressive matrices (RCPM) with a (18)F-fluorodeoxyglucose (FDG)-position emission tomography (PET) measurement of resting state. We evaluated a relationship between performance of neuropsychological tests and regional cerebral glucose metabolism using voxel-based analysis.
RESULTS: Poor performance in three-word delayed recall was related to glucose hypometabolism in the right medial temporal, right prefrontal, and left superior parietal cortices. The deficit in visual delayed recall of RCF correlated positively with hypometabolism in the bilateral posterior cingulate. The impairment in two-relational reasoning was associated with hypometabolism in the right prefrontal cortex.
CONCLUSIONS: The present findings suggest that hypometabolism in the right medial temporal cortex, right prefrontal cortex, left superior parietal cortex, and bilateral posterior cingulate reflects impairments in delayed recall while hypometabolism in the right prefrontal cortex mirrors deficits in executive function in MCI.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19018949     DOI: 10.1111/j.1552-6569.2008.00328.x

Source DB:  PubMed          Journal:  J Neuroimaging        ISSN: 1051-2284            Impact factor:   2.486


  7 in total

1.  Relationship between baseline brain metabolism measured using [¹⁸F]FDG PET and memory and executive function in prodromal and early Alzheimer's disease.

Authors:  Christian Habeck; Shannon Risacher; Grace J Lee; M Maria Glymour; Elizabeth Mormino; Shubhabrata Mukherjee; Sungeun Kim; Kwangsik Nho; Charles DeCarli; Andrew J Saykin; Paul K Crane
Journal:  Brain Imaging Behav       Date:  2012-12       Impact factor: 3.978

2.  Female advantage in verbal memory: Evidence of sex-specific cognitive reserve.

Authors:  Erin E Sundermann; Pauline M Maki; Leah H Rubin; Richard B Lipton; Susan Landau; Anat Biegon
Journal:  Neurology       Date:  2016-10-05       Impact factor: 9.910

3.  Executive deficits are related to the inferior frontal junction in early dementia.

Authors:  Matthias L Schroeter; Barbara Vogt; Stefan Frisch; Georg Becker; Henryk Barthel; Karsten Mueller; Arno Villringer; Osama Sabri
Journal:  Brain       Date:  2011-12-19       Impact factor: 13.501

4.  Functional assessment of prefrontal lobes in patients with major depression disorder using a dual-mode technique of 3D-arterial spin labeling and 18F-fluorodeoxyglucose positron emission tomography/computed tomography.

Authors:  Chang Fu; Dapeng Shi; Yongju Gao; Junling Xu
Journal:  Exp Ther Med       Date:  2017-06-13       Impact factor: 2.447

5.  The Brain Metabolic Correlates of the Main Indices of Neuropsychological Assessment in Alzheimer's Disease.

Authors:  Agostino Chiaravalloti; Maria Ricci; Daniele Di Biagio; Luca Filippi; Alessandro Martorana; Orazio Schillaci
Journal:  J Pers Med       Date:  2020-04-18

Review 6.  Higher-Level Executive Functions in Healthy Elderly and Mild Cognitive Impairment: A Systematic Review.

Authors:  Ilaria Corbo; Maria Casagrande
Journal:  J Clin Med       Date:  2022-02-23       Impact factor: 4.241

7.  Resting-state abnormalities in amnestic mild cognitive impairment: a meta-analysis.

Authors:  W K W Lau; M-K Leung; T M C Lee; A C K Law
Journal:  Transl Psychiatry       Date:  2016-04-26       Impact factor: 6.222

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.